CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income			$ 2,453	$ 46,094
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation			39	49
Stock-based compensation expense			3,311	3,314
Loss on issuance of warrants			75,644
Change in fair value of convertible notes	$ 1,854	$ (1,795)	3,485	(1,708)
Change in fair value of warrants	542	(5,905)	(86,187)	14,999
Change in fair value of embedded forward purchase agreements and derivative liabilities		(2,905)		20,012
Change in fair value of contingent consideration	16	(161,233)	(3,472)	(97,464)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets			(245)	487
Accounts payable			(2,003)	(358)
Accrued expenses and other liabilities			(3,018)	(2,263)
Other assets and liabilities			(7)	122
Net cash used in operating activities			(10,000)	(16,716)
Cash flows from investing activities:
Purchases of property and equipment			(4)
Net cash used in investing activities			(4)
Cash flows from financing activities:
Proceeds from issuance of convertible notes				15,000
Proceeds from issuance of at-the-market shares, net			84
Proceeds from issuance of public offering shares, net			18,346
Net cash provided by financing activities			18,430	15,000
Net increase (decrease) in cash			8,426	(1,716)
Cash and cash equivalents at beginning of period			13	5,158
Cash and cash equivalents at end of period	$ 8,439	$ 3,442	8,439	$ 3,442
Non-cash financing activities:
Cashless warrant exercises			$ 6,864